Patients with a history of a prior BCC had significantly lower levels of CD3ε, CD25, CD68, and ICAM-1 mRNA (p = 0.01, p = 0.01, p = 0.005, p = 0.03, respectively). This evidence concerns the gene CD68 and skin basal cell carcinoma.